The dominant effects of the T allele of rs3181096 and the A allele of rs3181098 in the promoter region of CD28 conferred protective effects on the development of GVHD in patients with AML (dominant model: p = 0.0231 and 0.0235, respectively). This evidence concerns the gene CD28 and graft versus host disease.